Ticker Details
C4 Therapeutics, Inc.
IPO Date:	October 2, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$492.1M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 4.25%
Avg Daily Range (30 D):	$0.12 | 3.07%
Avg Daily Range (90 D):	$0.14 | 3.68%

Institutional Daily Volume
Avg Daily Volume:	1.57M
Avg Daily Volume (30 D):	2.41M
Avg Daily Volume (90 D):	2.66M

Trade Size
Avg Trade Size (Sh.):	154
Avg Trade Size (Sh.) (30 D):	172
Avg Trade Size (Sh.) (90 D):	165

Institutional Trades
Total Institutional Trades:	1,132
Avg Institutional Trade:	$1.94M
Avg Institutional Trade (30 D):	$1.11M
Avg Institutional Trade (90 D):	$1.73M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.17M
Avg Closing Trade (30 D):	$.64M
Avg Closing Trade (90 D):	$2.06M
Avg Closing Volume:	206.55K

News

May 20, 2026 @ 11:00 AM C4 Therapeutics to Participate in Upcoming Confere... Source: Not Specified

Feb 4, 2026 @ 12:00 PM C4 Therapeutics to Participate in the Guggenheim E... Source: Na

Jan 14, 2026 @ 12:00 PM C4 Therapeutics Outlines Strategic Milestones to A... Source: C4 Therapeutics, Inc.

Nov 25, 2025 @ 12:00 PM C4 Therapeutics to Participate in the 8th Annual E... Source: C4 Therapeutics

Sep 15, 2025 @ 10:33 PM Why C4 Therapeutics Stock Crushed the Market on Mo... Source: Eric Volkman

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.91	$-.18	$-.2
Diluted EPS	$-.91	$-.18	$-.2
Revenue	$35.04M	$6.64M	$6.15M
Gross Profit
Net Income / Loss	$-101.42M	$-23.64M	$-25.13M
Operating Income / Loss	$-111.77M	$-26.42M	$-27.79M
Cost of Revenue
Net Cash Flow	$.45M	$17.34M	$-13.33M
PE Ratio